Order Products

0

COVID-19 ANTIGEN RAPID TEST DEVICE AT HOME TEST RESULTS IN MINUTES

$125.00
On Sale
was $150.00 Save 17%
Bulk pricing available for quantities of 6 units or more
In stock
Buy more, save more
Quantity Price per item Discount
6 items $110.00 12% off
Product Details

FWGE RX BioSCIENCE COVID-19: Our Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal secretion samples.

RESULTS IN MINUTES: FWGE RX BioSCIENCE COVID-19 Antigen Rapid Test Device is a self-test to detect whether an individual has COVID-19 and delivers results within 15 minutes!

EASY TO USE: Detailed written and diagram instructions are included in each test kit making it easy for its user to perform.

AT HOME CONVENIENCE: FWGE RX BioSCIENCE COVID-19 Antigen Rapid Test Device is an efficient, accurate, and reliable method of testing that can be used in the comfort of your home without the need to ship your sample to a lab.

PERFECT SCREENING TOOL: FWGE RX BioSCIENCE COVID-19 Antigen Rapid Test Device is the perfect screening tool for individuals, families, friends, and organizations that want to try to protect their home, events, schools, and workplaces from the risk of COVID-19 spread and potential workplace/school lockdowns. FWGE RX BioSCIENCE Nasal device offers fast, easy-to-use, and reliable screening. Testing can be done 1-2 times/week to help detect the virus early and decrease the likelihood of spreading COVID-19.

CONTENTS:

·5 Individually Packed Test Devices

· Extraction Buffer

·5 pack ‐ 5 Single use Buffer Vials

·5 Extraction Tubes

·5 Nozzles with Filters

·1 Tube Stand

·5 Individually Packed Swabs

Weight:

0.05 lbs.

Test Technology:

Antigen

Diagnostic Sensitivity:

78.6% - 96.2%

Diagnostic Specificity:

96.5% - 100%

Shelf Life (Expiry):

6-18 Months

Storage Temperature:

2-30°C/36-86°F

Time to Results:

15 Minutes

Sample Collection:

Shallow Nasal

FWGE RX BioSCIENCE COVID-19 Antigen Rapid Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal and nasopharyngeal secretions from individuals suspected of COVID-19 within 6 days of symptom onset.

Results are for the identification of SARS-CoV-2 viral nucleoprotein antigen. Antigens are generally detectable in nasopharyngeal and nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.

Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Individuals are required to report all positive results to the appropriate public health authorities.

Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history, and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient
management.

Share this product with your friends
COVID-19 ANTIGEN RAPID TEST DEVICE AT HOME TEST RESULTS IN MINUTES

According to the peer reviewed biomedical literature, the proprietary fermented wheat germ extract (FWGE), named as FWGE has significant anticancer and immune modulatory properties.1 In laboratory animals with impaired immunity, healthy immune functions were completely restored by orally administered FWGE.

 

Due to its positive effects on the immune functions, concomitantly administered FWGE will not reduce the efficacy of COVID-19 vaccines and FWGE may even advantageously impact the immune response to vaccination.


This statement is based on the following data.


In vivo cancer studies showed potent immune modulatory activity of FWGE.*

Administration of FWGE significantly increased the ratio of CD4+ T and NK cells and also remarkably activated the monocytes.


It has been well established that individuals who received vaccination against SARS-CoV-2, developed protective and enduring immunity with sustained T cell immune responses against the novel coronavirus.


When responding to the viral antigene, these T cells (mostly CD4+ and CD8+ T cells and the corresponding memory cells) produce effectors such as the antiviral cytokine interferon-gamma (IFN-γ) to protect the individual from virus infection.4


To prevent SARS-CoV-2 infection, CD4+ T cell responses are of primary importance and immunity is maintained by memory T cells. It has been reported that SARS-CoV-2 specific CD4+ T cells prevented serious COVID-19 disease in virus infected patients.


In COVID-19, the lack of CD4+ T cells was associated with lethal outcome. In laboratory experiments, IFN-γ produced by SARS-CoV-2 specific CD4+ T cells prevented fatal outcomes.


In COVID-19 vaccine clinical trials with BNT162b1, the vaccine developed by BioNTech and Pfizer, robust CD4+ T cell responses, interferon-γ production, and strong antibody responses against the receptor binding domains of the SARS-CoV-2 spike protein were found with even the low dose of the vaccine.


It can be stated that FWGE with its well-established immune modulatory properties, certainly shall not reduce the efficacy of COVID-19 vaccines.


There are signs indicating that administration of FWGE may even positively influence the specific immune response boosting activities of COVID-19 vaccines.


In broiler chickens, immunized against infective bursitis and fowl pest (Newcastle disease), specific antibody titers were significantly higher when the animals were fed with FWGE containing feeds. It has been concluded that administration of FWGE to farm animals favourably influences the immune response after vaccination. These results have been confirmed also by large scale immunization experiments with chickens and other farm animals. 


In conclusion, we can say that FWGE administered simultaneously with COVID-19 vaccines, definitely will not reduce the efficacy of immunization and will likely have a positive impact.


For wholesale professional use please contact us directly.

Share by: